Notably, BAI and Cu-PBS showed a trend toward reducing plaque area but did not achieve statistical significance.
← all excerpts
Carrier free oral Co-delivery of atorvastatin via baicalein-copper-network for atherosclerosis therapy through senescence reversal and multi-mechanistic synergy.
1
—
—